182 related articles for article (PubMed ID: 26715293)
1. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013).
Watanabe K; Shimo A; Tsugawa K; Tokuda Y; Yamauchi H; Miyai E; Takemura K; Ikoma A; Nakamura S
Support Care Cancer; 2016 Jun; 24(6):2583-90. PubMed ID: 26715293
[TBL] [Abstract][Full Text] [Related]
2. The effect of topical 0.75% metronidazole gel on malodorous cutaneous ulcers.
Finlay IG; Bowszyc J; Ramlau C; Gwiezdzinski Z
J Pain Symptom Manage; 1996 Mar; 11(3):158-62. PubMed ID: 8851373
[TBL] [Abstract][Full Text] [Related]
3. Use of metronidazole gel to control malodor in advanced and recurrent breast cancer.
Kuge S; Tokuda Y; Ohta M; Okumura A; Kubota M; Ninomiya S; Sawamura S; Makuuchi H; Tajima T; Mitomi T
Jpn J Clin Oncol; 1996 Aug; 26(4):207-10. PubMed ID: 8765176
[TBL] [Abstract][Full Text] [Related]
4. Topical metronidazole for the treatment of wound odor: a review of the literature.
Paul JC; Pieper BA
Ostomy Wound Manage; 2008 Mar; 54(3):18-27; quiz 28-9. PubMed ID: 18382045
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours.
Bower M; Stein R; Evans TR; Hedley A; Pert P; Coombes RC
Eur J Cancer; 1992; 28A(4-5):888-9. PubMed ID: 1524917
[TBL] [Abstract][Full Text] [Related]
6. Metronidazole use in malodorous skin lesions.
Rice TT
Rehabil Nurs; 1992; 17(5):244-5, 255. PubMed ID: 1448604
[TBL] [Abstract][Full Text] [Related]
7. Topical agents and dressings for fungating wounds.
Adderley UJ; Holt IG
Cochrane Database Syst Rev; 2014 May; 2014(5):CD003948. PubMed ID: 24832784
[TBL] [Abstract][Full Text] [Related]
8. Topical agents and dressings for fungating wounds.
Adderley U; Smith R
Cochrane Database Syst Rev; 2007 Apr; (2):CD003948. PubMed ID: 17443534
[TBL] [Abstract][Full Text] [Related]
9. The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea.
Wolf JE; Del Rosso JQ
Cutis; 2007 Jan; 79(1):73-80. PubMed ID: 17330626
[TBL] [Abstract][Full Text] [Related]
10. Polyhexanide Versus Metronidazole for Odor Management in Malignant (Fungating) Wounds: A Double-Blinded, Randomized, Clinical Trial.
Villela-Castro DL; Santos VLCG; Woo K
J Wound Ostomy Continence Nurs; 2018; 45(5):413-418. PubMed ID: 30086103
[TBL] [Abstract][Full Text] [Related]
11. A topical metronidazole gel used to treat malodorous wounds.
Bale S; Tebbie N; Price P
Br J Nurs; 2004 Jun; 13(11):S4-11. PubMed ID: 15218439
[TBL] [Abstract][Full Text] [Related]
12. Topical Metronidazole for Odor Control in Pressure Ulcers.
Lyvers E; Elliott DP
Consult Pharm; 2015 Sep; 30(9):523-6. PubMed ID: 26350892
[TBL] [Abstract][Full Text] [Related]
13. Improving malodour management in advanced cancer: a 10-year retrospective study of topical, oral and maintenance metronidazole.
George R; Prasoona TS; Kandasamy R; Cherian R; Celine T; Jeba J; Murali S; Mathew D
BMJ Support Palliat Care; 2017 Sep; 7(3):286-291. PubMed ID: 28174164
[TBL] [Abstract][Full Text] [Related]
14. Metronidazole in smelly tumours.
Ashford RF; Plant GT; Maher J; Pickering D; Coe MA; Drury A; Goold MA; Teare EL
Lancet; 1980 Apr; 1(8173):874-5. PubMed ID: 6103225
[No Abstract] [Full Text] [Related]
15. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
16. Systemic antibiotics for treating malignant wounds.
Ramasubbu DA; Smith V; Hayden F; Cronin P
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011609. PubMed ID: 28837757
[TBL] [Abstract][Full Text] [Related]
17. Case study: eliminating odors from wounds.
Poteete V
Decubitus; 1993 Jul; 6(4):43-6. PubMed ID: 8297491
[TBL] [Abstract][Full Text] [Related]
18. Topical metronidazole maintains remissions of rosacea.
Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
[TBL] [Abstract][Full Text] [Related]
19. [An efficient method to reduce odors].
Finlay IG
Krankenpfl Soins Infirm; 1999 Mar; 92(3):72-5. PubMed ID: 10455650
[No Abstract] [Full Text] [Related]
20. Bacteriology and treatment of malodorous lower reproductive tract in gynecologic cancer patients.
Von Gruenigen VE; Coleman RL; Li AJ; Heard MC; Miller DS; Hemsell DL
Obstet Gynecol; 2000 Jul; 96(1):23-7. PubMed ID: 10862836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
